Your browser doesn't support javascript.
loading
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.
Romano, Gabriele; Paradiso, Francesca; Li, Peng; Shukla, Pooja; Barger, Lindsay N; El Naggar, Olivia; Miller, John P; Liang, Roger J; Helms, Timothy L; Lazar, Alexander J; Wargo, Jennifer A; Taraballi, Francesca; Costello, James C; Kwong, Lawrence N.
Afiliação
  • Romano G; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
  • Paradiso F; Immune Cell Regulation & Targeting Program, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Li P; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shukla P; Center for Musculoskeletal Regeneration, Department of Orthopedics & Sports Medicine, Houston Methodist Research Institute, Houston, Texas.
  • Barger LN; Reproductive Biology and Gynecological Oncology Group, Swansea University Medical School, Swansea, United Kingdom.
  • El Naggar O; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Miller JP; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liang RJ; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
  • Helms TL; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
  • Lazar AJ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wargo JA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Taraballi F; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Costello JC; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kwong LN; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Immunol Res ; 11(5): 558-569, 2023 05 03.
Article em En | MEDLINE | ID: mdl-36820825
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Melanoma Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Melanoma Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article